Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
Penn helped test an mRNA cancer vaccine that succeeded in its late-stage clinical trial. “This was kind of the wake-up call that RNA vaccines in cancer have an enormous future,” Drew Weissman said.
← Back to stories
2 articles from 1 source across the spectrum· Updated 7d ago
1 across the spectrum · tap a section to jump
Left
1 viewpointPenn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
Center
0 viewpointsNo Center coverage yet.
A blind spot on this side of the story.
Right
0 viewpointsNo Right coverage yet.
A blind spot on this side of the story.